USA flag logo/image

An Official Website of the United States Government

Use of Spray-Drying as a Manufacturing Process for Oral Adenovirus Vaccine

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
R43GM101737
Solicitation Year:
2012
Solicitation Topic Code:
NIGMS
Solicitation Number:
PA09-113
Small Business Information
PAXVAX, INC.
3985A SORRENTO VALLEY BLVD SAN DIEGO, CA 92121
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2012
Title: Use of Spray-Drying as a Manufacturing Process for Oral Adenovirus Vaccine
Agency: HHS
Contract: 1R43GM101737-01
Award Amount: $298,464.00
 

Abstract:

DESCRIPTION (provided by applicant): The 2009 H1N1 pandemic illustrates a critical weakness in our ability to respond to a pandemic threat. The ability to ramp up production of vaccine doses within the critical period from the discovery of the threat is hindered by two major supply constrictions: 1) production technology for producing influenza vaccines in eggs; and 2) the logistical considerations involved in deploying and delivering a refrigerated parenteral vaccine by trained personnel. Our Ad 4 vaccinevector encoding influenza antigens and a delivered oral dosage form addresses both of these issues. This project focuses on developing a old technique to be applied in a new way to increase the speed and scale of producing live vaccine powder in both a convention form and in a coated form. That technique utilizes spray drying to replace lyophilization as a drying method. The program also consists of enteric coating of adenovirus technology that can be incorporated in a manufacturing process suitable for drying the vector. Spray drying is unique in that the coating and drying process are achieved simultaneously. The resulting enteric coated vector platform could be used for widely different vaccine applications, and would therefore save both time and money indevelopment of vaccines against emerging diseases, bioterror threats, and pandemics. PUBLIC HEALTH RELEVANCE: Spray Drying, a simple and versatile manufacturing process to make powder products in bulk for vaccines and biologics. Spray drying process for biologics allows meeting any emergency needs at low cost per dose through economies of scale. A Spray Drying process manufacturing site can be commissioned anywhere in the world in the event of an emergency situation.

Principal Investigator:

Amish Patel
858-450-9595
apatel@paxvax.com

Business Contact:

Kenneth J. Kelley
858-450-9595
banderson@paxvax.com
Small Business Information at Submission:

PAXVAX, INC.
3985A SORRENTO VALLEY BLVD SAN DIEGO, CA 92121

EIN/Tax ID: 111378050
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No